Table 1.
Demographic And Clinicopathological Characters Of NM Patients
| N (%) | N (%) | ||
|---|---|---|---|
| Gender | Symptoms and signs | ||
| Male | 133 (67.17) | Intracranial | |
| Female | 65 (32.83) | Headache | 9 (4.55) |
| Age | Epilepsy | 8 (4.04) | |
| < 15 y | 96 (48.48) | Ataxia | 5 (2.53) |
| ≥ 15 y | 102 (51.52) | Vomiting | 5 (2.53) |
| Primary tumors | Blurred vison | 3 (1.52) | |
| Embryonal tumors | Tinnitus | 2 (1.01) | |
| Medulloblastoma | 68 (34.34) | Hearing loss | 2 (1.01) |
| PNET | 6 (3.03) | Dizziness | 2 (1.01) |
| AT/RT | 2 (1.01) | Bucking | 1 (0.51) |
| Esthesioneuroblastoma | 2 (1.01) | Diplopia | 1 (0.51) |
| GCTs | Intraspinal | ||
| Mixed GCTs | 21 (10.61) | Back pain | 22 (11.11) |
| Germinomas | 17 (8.59) | Extremity weakness | 17 (8.59) |
| Glioma | Extremity numbness | 16 (8.08) | |
| Glioblastoma | 15 (7.58) | Extremity ache | 7 (3.54) |
| Astrocytic tumors | Bowel/bladder dysfunction | 6 (3.03) | |
| Astrocytoma | 7 (3.54) | Ataxia | 4 (2.02) |
| Anaplastic astrocytoma | 2 (1.01) | Impotence | 1 (0.51) |
| Astroblastoma | 1 (0.51) | Treatment | |
| Pilocytic astrocytoma | 3 (1.52) | Operation for NM | |
| Oligodendroglial tumors | Intracranial | ||
| Anaplastic oligodendroglioma | 1 (0.51) | Approaches | |
| Oligodendroglioma | 1 (0.51) | Removal | 24 (12.12) |
| Astrocytic and oligodendroglia tumors | Biopsy | 4 (2.02) | |
| Astrocytic-oligodendroglioma | 1 (0.51) | Sites | |
| Anaplastic Astrocytic-oligodendroglioma | 4 (2.02) | Anterior skull base | 6 (3.03) |
| Ependymal tumors | Lateral ventricles | 6 (3.03) | |
| Anaplastic ependymoma | 9 (4.55) | Third ventricles | 4 (2.02) |
| Ependymoma | 6 (3.03) | CPA | 4 (2.02) |
| PPTs | Cerebral hemisphere | 2 (1.01) | |
| PPTID | 6 (3.03) | Cerebellar hemisphere | 2 (1.01) |
| Pineoblastoma | 4 (2.02) | Premedullary cistern | 2 (1.01) |
| Choroid plexus tumors | Suprasellar cistern | 1 (0.51) | |
| Choroid plexus carcinoma | 3 (1.52) | Cisterna magna | 1 (0.51) |
| Atypical choroid plexus papilloma | 1 (0.51) | Intraspinal | |
| Choroid plexus papilloma | 1 (0.51) | LIa | 1 (0.51) |
| Tumors of the sellar region | LIIb | 2 (1.01) | |
| Craniopharyngioma | 1 (0.51) | NI | 10 (5.05) |
| Pituitary adenoma | NIIa | 1 (0.51) | |
| Nonfunctional pituitary adenoma | 2 (1.01) | Intramedullary | 1 (0.51) |
| Growth hormone pituitary adenoma | 1 (0.51) | Chemo-/radiotherapy | |
| Meningiomas | CT alone | 38 (19.19) | |
| Anaplastic meningioma | 1 (0.51) | RT alone | 20 (10.10) |
| Rhabdoid meningioma | 2 (1.01) | CT + RT | 110 (55.56) |
| PCNSL | 5 (2.53) | Prognosis | |
| Malignant schwannoma | 1 (0.51) | Death | 98 (61.63) |
| Melanoma | 1 (0.51) | Alive | |
| Neuronal-glial tumor | 1 (0.51) | Improved | 38 (23.90) |
| Others | Stabled | 16 (10.06) | |
| Small cell malignant tumor | 1 (0.51) | Progressed | 7 (4.40) |